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• Sepsis is a dysregulated host response to an infection. During 
sepsis, dysfunction of pulmonary microvascular endothelial cells 
(PMVEC) often occurs resulting in a loss of barrier function [1]. 
• Interactions between PMVEC and the extracellular matrix (ECM) 
support the stability of the PMVEC barrier [2]. 
• Metalloproteinases are a family of enzymes capable of remodeling 
the ECM [3].
• Tissue inhibitor of metalloproteinase 3 (TIMP3) is an endogenous 
inhibitor of metalloproteinases. TIMP3 is important for 
maintaining normal barrier function and TIMP3 levels appear
to be decreased under septic conditions [1][3]. 
• Previous work has demonstrated that a number of cellular 
processes are altered in Timp3-/- PMVEC vs. WT PMVEC under basal 
conditions, including a decrease in cell-ECM interactions [4].
• Proteomic analysis, including Terminal Amino Isotopic Labeling of 
Substrates (TAILS), has identified several peptides to be 
differentially abundant in Timp3-/- PMVEC compared to WT PMVEC 
[4]. 
Study Objectives 
1. To validate the levels of proteins that were previously identified 
to be differentially abundant between Timp3-/- and WT PMVEC.
• Fibronectin, Integrin alpha-5, Annexin A1
2. To determine how the abundance of these proteins changes 
under septic conditions.
Hypothesis
We hypothesize that TIMP3 regulates PMVEC barrier function by 
promoting PMVEC-ECM interactions.
Fig. 2 Gene Overlap Analysis for Timp3-/-
and WT PMVEC.
Fig. 1 Enriched Ontology Clusters for Timp3-/-
and WT PMVEC [4].
Fig. 5 Venny showing overlap between peptides identified to be differentially represented in preTAILS and TAILS 
proteomic assay for Timp3-/- and WT PMVEC.




↓ Integrin alpha-5 
↓ Annexin A1 
↑ Neogenin 
↑ Exostosin-1 
Fig. 3 Differentially abundant peptides for Timp3-/- PMVEC in comparison to WT 
PMVEC, as identified by preTAILS and TAILS assay. 
• Increase the sample size and continue to validate the 
abundance of other differentially represented peptides.
• Determine how the amount of fibronectin produced by PMVEC 
in vitro changes over time. 
• Explore whether there is altered gene transcription in Timp3-/-
PMVEC compared to WT PMVEC using qRT-PCR.
• Perform leak studies using trans-PMVEC monolayer Evans Blue-
albumin flux to assess if there is a relationship between protein 
levels and leak.
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Fig. 6 Western blot showing protein abundance under basal conditions for (A, B) fibronectin, (C, D) annexin A1, 
and (E, F) integrin alpha-5, relative to GAPDH loading control. There were no significant differences between 
levels of fibronectin (n=5, P=0.8516), annexin A1 (n=4, P=0.8815) or integrin alpha-5 (n=4, P=0.7878) in WT and 
Timp3-/- PMVEC (paired two-tailed T-test).
Fig. 8 (A) Western blot and (B) densitometric 
ratios for fibronectin from WT and Timp3-/-
PMVEC after 4hr treatment with PBS or 
cytomix (n= 3-5). There is a trend of 
decreasing fibronectin levels after 4hr 
cytomix treatment compared to PBS, in both 
WT and Timp3-/- PMVEC.
Fig. 7 (A) Western blot and (B) densitometric 
ratios for integrin alpha-5 from WT or Timp3-/-
PMVEC after 4hr treatment with PBS or 
cytomix (n= 2-4). There appears to be no 
change in integrin alpha-5 levels after 4hr 
cytomix treatment.
1. PMVEC were collected from Timp3-/-
mice and WT control mice.
2. Cultured PMVEC were seeded onto 
a 6-well gelatin-coated plate.
3. Once confluent, cells were treated 
for 4hr with PBS (basal) or 30 ng/mL 
cytomix, an equimolar combination 
of three sepsis-relevant cytokines 
(interleukin 1#, tumor necrosis 
factor $, interferon %).
4. Cells were lysed and the cell lysates 
were collected. 
5. Protein abundance was assessed by 
western blot. 
6. Densitometry was performed using 
ImageJ and statistical analysis was 
performed using GraphPad Prism. 
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